Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074Joon H. Uhm, Kurt A. Jaeckle, Patrick J. Flynn et al.|International Journal of Radiation Oncology*Biology*Physics|2010Cited by 186